Abortion Pill Opponents Seize New Chance to Target FDA Approval

Nov. 23, 2022, 10:25 AM UTC

A Christian advocacy group’s first-of-its kind lawsuit before a Trump-appointed Texas judge poses the greatest legal threat in years to access to abortion pills in America.

The lawsuit Alliance Defending Freedom filed Friday claims the Food and Drug Administration exceeded its authority when it used an accelerated process typically reserved for serious or life-threatening illnesses to approve mifepristone, a drug that coupled with another can be used to end a pregnancy within the first 10 weeks.

Since that decision in 2000, the use of abortion pills has steadily climbed among medical providers. It accounted for 54% of all US abortions ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.